Clinical Characteristics of BSCC Patients: Those With (n = 51) and Without (n = 51) PET
| Clinical characteristic | PET | P | ||
|---|---|---|---|---|
| With | Without | |||
| Age (y) | ||||
| ≤40 | 5 (10) | 9 (18) | 0.389 | |
| >40 | 46 (90) | 42 (82) | ||
| Sex | ||||
| M | 49 (96) | 50 (98) | 1.000 | |
| F | 2 (4) | 1 (2) | ||
| Cell type | ||||
| WD SCC + MD SCC | 48 (94) | 44 (86) | 0.318 | |
| PD SCC | 3 (6) | 7 (14) | ||
| AJCC c-stage | ||||
| I–II | 15 (29) | 16 (31) | 1.000 | |
| III–IV | 36 (71) | 35 (69) | ||
| AJCC p-stage | ||||
| I–II | 14 (27) | 16 (31) | 0.661 | |
| III–IV | 37 (73) | 35 (69) | ||
| Mode of primary treatment | ||||
| With free-flap reconstruction | 46 (90) | 48 (94) | 0.715 | |
| Without free-flap reconstruction | 5 (10) | 3 (6) | ||
| With neck dissection | 49 (96) | 46 (90) | 0.436 | |
| Without neck dissection | 2 (4) | 5 (10) | ||
| Surgery | 19 (37) | 24 (49) | 0.230 | |
| Surgery + RT/CCRT | 32 (63) | 27 (51) | ||
WD = well differentiated; SCC = squamous cell carcinoma; MD = moderately differentiated; PD = poorly differentiated; AJCC = American Joint Committee on Cancer; c-stage = clinical stage; p-stage = pathologic stage; CCRT = concurrent chemoradiation therapy.
Data are expressed as number (%) with and without PET.